FDA 延长了 ProSense 冷冻消融系统 De Novo 上市许可申请的审查期，预计将在 2025 年第一季度后就 ProSense 用于内分泌治疗早期低风险乳腺癌做出授权决定。 此更新来自 FDA 和 IceCure Medical 之间持续的讨论，标志着对这项创新技术的持续和彻底评估。

近日美国移民政策风起云涌，总统提出的“黄金绿卡”目前只是口头说辞，尚未正式立法提出， ...

Editor's note: Despite facing multiple challenges from both internal and external pressures, China's economy has remained stable, successfully meeting its major annual economic growth targets for ...

After the release of the 2025 Government Work Report, China Daily Website consulted two large AI language models, to sort out the top ten frequently mentioned keywords in the report. Let's take a ...